#1 Clinical Trials Search in Europe by CTIN

Our offer Newsroom

Find a treatment: By disease

Search all trials

Find therapies in clinical trials near you – page 32

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Magnetic resonance imaging+1

Not recruiting

Registered drugNo placebo

Study Comparing Gadoquatrane with Gadoteric Acid, Gadobutrol, and Gadoteridol for MRI in Adults with Brain or Spinal Cord Issues

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Gadobutrol

Contact Research Centre

Dermatitis atopic

Not recruiting

Registered drug

Study of Upadacitinib and Topical Corticosteroids for Adolescents and Adults with Moderate to Severe Eczema

Registered drug

Germany

Participants:0–17 years · 18–64 years · 65+ years
Substances:Hydrocortisone

Contact Research Centre

Study on Rituximab and Drug Combination for Treating Aggressive B-cell Lymphoma and Leukemia in Children and Adolescents

Not recruiting

Registered drugNo placebo

Study on Rituximab and Drug Combination for Treating Aggressive B-cell Lymphoma and Leukemia in Children and Adolescents

Registered drugNo placebo

Germany

Participants:0–17 years
Substances:Abiraterone Acetate

Contact Research Centre

Colitis ulcerative

Not recruiting

Investigational

Study on the Effects of GS-5290 for Patients with Moderate to Severe Ulcerative Colitis

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:(Phosphonooxy)Methyln-[(S)-[1-(Bicyclo[1.1.1]Pentan1-Yl)-1H-1,2,3-Triazol-4-Yl](2-Methyl-1-Oxo-1,2-Dihydroisoquinolin-5-Yl)Methyl]-N-{8-Chloro-3-Cyano-4-[(2,2-Dimethylpropyl)Amino]Quinolin-6-Yl]Carbamate

Contact Research Centre

Follicular lymphoma+2

Not recruiting

Registered drugNo placebo

Study Comparing Odronextamab and Lenalidomide with Rituximab and Lenalidomide for Patients with Relapsed/Refractory Follicular and Marginal Zone Lymphoma

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Lenalidomide

Contact Research Centre

Malignant melanoma

Not recruiting

Registered drug

Study Comparing Pembrolizumab and Placebo for Patients with Resected High-Risk Stage II Melanoma

Registered drug

Germany

Participants:0–17 years · 18–64 years · 65+ years
Substances:Pembrolizumab

Contact Research Centre

Deafness neurosensory

Not recruiting

Investigational

Study on ACOU085 to Prevent Hearing Loss in Testicular Cancer Patients Receiving Cisplatin

Investigational

Germany

Participants:18–64 years
Substances:Acou085

Contact Research Centre

Dermatitis atopic

Not recruiting

InvestigationalNo placebo

Study on the Effectiveness and Safety of Lebrikizumab for Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis

InvestigationalNo placebo

Germany

Participants:0–17 years · 18–64 years · 65+ years
Substances:Lebrikizumab

Contact Research Centre

Dermatitis atopic

Not recruiting

Investigational

Study on the Effects of LEO 138559 for Adults with Moderate-to-Severe Atopic Dermatitis

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Humanised Igg1 Monoclonal Antibody Against Interleukin 22 Receptor Subunit Alpha

Contact Research Centre

Retinal artery occlusion

Not recruiting

Registered drug

Study on Alteplase for Vision Recovery in Patients with Acute Central Retinal Artery Occlusion

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Tenecteplase

Contact Research Centre

Chronic spontaneous urticaria

Not recruiting

Investigational

Study on the Effects and Safety of Povorcitinib for Adults with Chronic Spontaneous Urticaria

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Povorcitinib

Contact Research Centre

Hidradenitis

Not recruiting

Investigational

Study on Izokibep for Patients with Moderate to Severe Hidradenitis Suppurativa

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Izokibep

Contact Research Centre

Explore other searches

Helpful resources

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.